XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
Hangzhou Gaoxin Materials Technology
300478
Beijing Philisense Technology
300287
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 5.06%556.77M | 8.71%359.75M | 11.95%163.24M | -1.55%738.12M | -8.31%529.96M | -13.48%330.93M | -24.62%145.82M | 4.90%749.74M | 577.96M | 19.66%382.48M |
Operating revenue | 5.06%556.77M | 8.71%359.75M | 11.95%163.24M | -1.55%738.12M | -8.31%529.96M | -13.48%330.93M | -24.62%145.82M | 4.90%749.74M | --577.96M | 19.66%382.48M |
Other operating revenue | ---- | 13.63%5.19M | ---- | -18.61%8.93M | ---- | -29.99%4.57M | ---- | -27.66%10.97M | ---- | --6.53M |
Total operating cost | 2.12%410.08M | 2.70%258.29M | -3.12%116.56M | -8.49%562.86M | -14.81%401.57M | -21.15%251.49M | 120.31M | 0.16%615.07M | 471.4M | 318.95M |
Operating cost | 4.83%375.31M | 4.82%241.46M | 9.70%108.6M | -9.45%501.07M | -16.60%358.01M | -19.40%230.36M | --98.99M | 3.67%553.38M | --429.27M | --285.82M |
Operating tax surcharges | 29.41%5.45M | 27.42%3.63M | 32.22%1.85M | -8.40%5.05M | 4.06%4.21M | 11.05%2.85M | --1.4M | 43.79%5.52M | --4.05M | --2.56M |
Operating expense | -5.42%8.05M | -0.05%5.27M | -35.05%2.32M | -1.56%11.3M | -6.67%8.51M | -5.40%5.28M | --3.58M | 14.06%11.47M | --9.11M | --5.58M |
Administration expense | -3.41%22.48M | 8.75%15.36M | -5.83%7.25M | 6.62%32.01M | 6.40%23.27M | -7.42%14.13M | --7.69M | 0.11%30.02M | --21.87M | --15.26M |
Financial expense | -65.34%-27.14M | -41.30%-23.19M | -815.50%-10.01M | -10.69%-19.93M | 4.57%-16.42M | -175.87%-16.41M | --1.4M | -331.18%-18M | ---17.2M | ---5.95M |
-Interest expense (Financial expense) | -72.40%594.33K | -74.83%440.65K | -68.71%216.21K | -61.93%1.28M | -15.38%2.15M | -9.14%1.75M | --691.1K | -39.64%3.36M | --2.54M | --1.93M |
-Interest Income (Financial expense) | -266.89%-27.39M | -260.57%-18.47M | -421.89%-10.07M | -196.77%-17.2M | -85.10%-7.47M | -137.46%-5.12M | ---1.93M | -81.20%-5.8M | ---4.03M | ---2.16M |
Research and development | 8.12%25.93M | 3.04%15.75M | -9.59%6.55M | 2.03%33.35M | -1.29%23.99M | -2.44%15.29M | --7.25M | 14.20%32.69M | --24.3M | --15.67M |
Credit Impairment Loss | 121.40%655.06K | 114.16%381.74K | 220.89%247.14K | -333.13%-2.82M | -3,055.73%-3.06M | -172.60%-2.7M | ---204.44K | 127.32%1.21M | --103.55K | ---988.88K |
Asset Impairment Loss | 22.72%-2.15M | 16.87%-2.06M | 25.64%-791.72K | 8.55%-3.25M | 7.04%-2.79M | -8.52%-2.48M | ---1.06M | -25.78%-3.56M | ---3M | ---2.28M |
Other net revenue | 185.50%2.2M | 95.30%-112.15K | 0.28%1.19M | 21.78%-1.26M | 23.53%-2.57M | -52.39%-2.38M | 1.18M | -145.60%-1.61M | -3.36M | -1.56M |
Fair value change income | 194.07%418.83K | 214.23%284.64K | -170.58%-55.26K | 94.93%-184.35K | 93.86%-445.21K | 94.59%-249.17K | --78.29K | -214.44%-3.63M | ---7.25M | ---4.6M |
Invest income | 1,163.86%2.24M | 525.74%1.11M | 50.14%477.34K | 110.56%356.84K | 479.91%176.95K | -85.19%176.95K | --317.94K | -259.56%-3.38M | ---46.58K | --1.19M |
Asset deal income | ---1.78M | ---1.77M | --103.35K | -172.40%-88.49K | --0 | ---- | ---- | -42.92%122.23K | --161.25K | --118.47K |
Other revenue | -20.31%2.83M | -32.07%1.94M | -41.35%1.21M | -38.04%4.73M | -46.80%3.55M | -42.74%2.86M | --2.06M | 44.73%7.63M | --6.66M | --4.99M |
Operating profit | 18.34%148.88M | 31.53%101.35M | 79.36%47.86M | 30.78%174.01M | 21.92%125.81M | 24.34%77.06M | -15.27%26.69M | 27.81%133.05M | 103.2M | 25.98%61.97M |
Add:Non operating Income | 46,759.73%8M | 46,758.72%8M | --8M | 401.51%102.22K | 3.39%17.08K | 21.82%17.08K | ---- | -90.10%20.38K | --16.52K | --14.02K |
Less:Non operating expense | 190.19%412.41K | -49.66%77.84K | -97.25%2.82K | 296.15%156.86K | 377.18%142.12K | 523.20%154.63K | --102.56K | -81.96%39.6K | --29.78K | --24.81K |
Total profit | 24.50%156.48M | 42.07%109.27M | 110.13%55.86M | 30.76%173.96M | 21.81%125.69M | 24.14%76.92M | -15.56%26.58M | 27.81%133.04M | 103.18M | 1,256,283.00%61.96M |
Less:Income tax cost | 3.94%19.64M | 33.28%14.78M | 173.37%8.84M | 131.62%24.21M | 82.98%18.89M | 188.69%11.09M | --3.23M | -21.98%10.45M | --10.32M | --3.84M |
Net profit | 28.13%136.84M | 43.55%94.49M | 101.38%47.02M | 22.16%149.74M | 15.01%106.79M | 13.26%65.83M | -12.95%23.35M | 35.16%122.58M | 92.86M | 35.47%58.12M |
Net profit from continuing operation | 28.13%136.84M | 43.55%94.49M | 101.38%47.02M | 22.16%149.74M | 15.01%106.79M | 13.26%65.83M | --23.35M | 35.16%122.58M | --92.86M | --58.12M |
Net profit of parent company owners | 28.13%136.84M | 43.55%94.49M | 101.38%47.02M | 22.16%149.74M | 15.01%106.79M | 13.26%65.83M | -12.95%23.35M | 35.16%122.58M | --92.86M | 35.47%58.12M |
Earning per share | ||||||||||
Basic earning per share | -3.88%1.24 | 7.50%0.86 | 53.57%0.43 | 12.75%1.68 | 14.16%1.29 | 14.29%0.8 | --0.28 | 35.45%1.49 | --1.13 | --0.7 |
Diluted earning per share | -3.88%1.24 | 7.50%0.86 | 53.57%0.43 | 12.75%1.68 | 14.16%1.29 | 14.29%0.8 | --0.28 | 35.45%1.49 | --1.13 | --0.7 |
Other composite income | 375.87%7.06M | -707.18%-3.59M | -7,550.78%-3.53M | -10.86%2.07M | -240.10%-2.56M | 640.76%590.82K | -46.12K | 189.33%2.32M | -752.55K | -109.26K |
Other composite income of parent company owners | 375.87%7.06M | -707.18%-3.59M | -7,550.78%-3.53M | -10.86%2.07M | -240.10%-2.56M | 640.76%590.82K | ---46.12K | 189.33%2.32M | ---752.55K | ---109.26K |
Total composite income | 38.05%143.9M | 36.87%90.9M | 86.63%43.49M | 21.54%151.81M | 13.17%104.24M | 14.49%66.42M | 23.3M | 41.79%124.9M | 92.11M | 58.01M |
Total composite income of parent company owners | 38.05%143.9M | 36.87%90.9M | 86.63%43.49M | 21.54%151.81M | 13.17%104.24M | 14.49%66.42M | --23.3M | 41.79%124.9M | --92.11M | --58.01M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.